Scientific workflow for hypothesis testing in drug discovery: Part 1
Drug Target Review
DECEMBER 6, 2024
In cases where control or treatment groups show large variability, this could reflect true biological responses to a treatment, and removing such data could reduce the accuracy of the analysis. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.
Let's personalize your content